(Q31161981)

English

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

0 references

0 references

prostate cancer screening

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

object named as

Hans Lilja

9

0 references

object named as

Andrew J Vickers

1

0 references

8

object named as

Jonas Hugosson

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

author name string

Angel M Cronin

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Gunnar Aus

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Carl-Gustav Pihl

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Charlotte Becker

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Kim Pettersson

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Peter T Scardino

7

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

language of work or name

0 references

publication date

8 July 2008

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

19

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Decision curve analysis: a novel method for evaluating prediction models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Cancer statistics, 2006

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Prostate specific antigen isoforms and human glandular kallikrein 2--which offers the best screening performance in a predominantly black population?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Differential exoprotease activities confer tumor-specific serum peptidome patterns

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Early detection of prostate cancer in African-American men through use of multiple biomarkers: human kallikrein 2 (hK2), prostate-specific antigen (PSA), and free PSA (fPSA).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Outcome of laterally directed sextant biopsies of the prostate in screened males aged 50--66 years. Implications for sampling order

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Sensitive and specific immunodetection of human glandular kallikrein 2 in serum.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Assessment of diagnostic tests when disease verification is subject to selection bias

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

Testing for fetal pulmonary maturity: ROC analysis involving covariates, verification bias, and combination testing.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2474851

14 July 2018

A multicenter clinical trial on the use of (-5, -7) pro prostate specific antigen.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-6-19

21 January 2018

The value of (-7, -5)pro-prostate-specific antigen and human kallikrein-2 as serum markers for grading prostate cancer

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-6-19

21 January 2018

Non-systematic screening for prostate cancer in Sweden--survey from the National Prostate Cancer Registry

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-6-19

21 January 2018

Development of sensitive immunoassays for free and total human glandular kallikrein 2.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-6-19

21 January 2018

Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-6-19

21 January 2018

Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab')2 fragments.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-6-19

21 January 2018

Standardization of two immunoassays for human glandular kallikrein 2.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-6-19

21 January 2018

Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146

1 reference

https://pubmed.ncbi.nlm.nih.gov/18611265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of chronic prostatitis lowers serum prostate specific antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/18611265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/18611265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population-based study of prostate-specific antigen testing and prostate cancer detection in clinical practice in northern Sweden

1 reference

https://pubmed.ncbi.nlm.nih.gov/18611265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practice patterns of clinicians following isolated diagnoses of atypical small acinar proliferation on prostate biopsy specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/18611265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/18611265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum

1 reference

https://pubmed.ncbi.nlm.nih.gov/18611265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples

1 reference

https://pubmed.ncbi.nlm.nih.gov/18611265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18611265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: studies in serum and plasma samples

1 reference

https://pubmed.ncbi.nlm.nih.gov/18611265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A meta-analysis of the performance characteristics of the free prostate-specific antigen test

1 reference

https://pubmed.ncbi.nlm.nih.gov/18611265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Finasteride on the Sensitivity of PSA for Detecting Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18611265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1741-7015-6-19

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31161981&oldid=2195114232"